Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats

Drug Development and Industrial Pharmacy

Volumn 32, Issue 4, 2006, Pages 413-422

  Li, Y ^a   Pan, W S ^a   Chen, S L ^b   Xu, H X ^c   Yang, D J ^b   Chan, A S C ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c Chinese Medicine Limited   (Hong Kong)

Author keywords

Excretion; HPLC; Phospholipid; Puerarin; Puerarin phospholipid complex; Serum kinetics; Tissue concentrations

Indexed keywords

PHOSPHOLIPID; PUERARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; COMPARTMENT MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; FECES; FEMALE; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; SPLEEN; URINE;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; ISOFLAVONES; MOLECULAR STRUCTURE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; VASODILATOR AGENTS;

EID: 33646490262     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600559123     Document Type: Article

References (28)

1. Bialecka, M. (1997). The Effect of bioflavonoids and lecithin on the course of experimental atherosclerosis in rabbits. Annu. Acad. Med. Stein., 43, 41.
2. Bombardelli, E., Patri, G., & Pozzi, R. (1992), Nov. 24. Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them. U.S. Patent 5, 166,139.
3. Elkheshen, S. A., Sammour, O. A., Al-Shaboury, M. H., & Al-Quadeib, B. T. (2001). Ehancement of dissolution and bioavailability of piroxicam via solid dispersion with phospholipid. B. Faculty. Pharm., 39(1), 309-320.
4. Gatti, G., & Peruua, E. (1994). Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex in healthy volunteers. Int. Clin. Pharmacol. Ther., 32(11), 614-620.
5. Guangxi, Z., Hongxiang, L., Dianzhou, B., & Lijia, Z. (2003). Bioavailability of Puerarin-phospholipid dispersion in rats. Ind. J. Pharm. Sci., 65(3), 285-287.
6. Guangxi, Z., Hongxiang, L., Dianzhou, B., & Lijia, Z. (2003). Interaction of Puerarin with phospholipid in solid dispersion. J. Chin. Pharm. Sci., 12(1), 36-40.
7. Hong, X. (1999). The pharmacokinetics of glycosides in chinese traditional and herbal medicine. In Pharmacokinetics of Chinese Traditional and Herbal Medicine, (1st Ed.) ISBN:7506721333, Guozhu, H., Ed.; Beijing, China: China Medical Science and Technology Publishing House, vol. 14, 317-319.
8. Jianmei, M., Dawei, C., & Ruhua, Z. (1999). Study on the bioavailability of PPC by using HPLC. Biomed. Chromatogr., 13, 493-495.
9. Jianping, G., & Tongying, Z. (1995). The study on the in vitro dissolution of Pueraria flavones dripping pill. Chin. Trad. Herb. Drugs., 26(6), 298-299.
10. Khazaeinia, T., & Jamili, F. (2003). A comparision of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt. J. Pharm. Pharm. Sci., 6(3), 351-358.
11. Kimura, S. (1986), Aug 28. Solubilization of dolichol with lipids. JP Patent 61,194,024.
12. Li, W., Dongming, X., Hong, L., Hong, S., Xijun, H., & Lijun, D. (2001). Excretion of Puerarin from the rats after CBN injection. Pharmacol. Clin. Chin. Mate. Med., 17(5), 8-10.
13. Lili, F., Dehua, Z., Minqi, Z., & Guiyun, Z. (1985). The effect of Pueraria flavones on the antiarrhythmia. Acta. Pharm. Sin., 20, 647-651.
14. Lili, F., Keefe, D. O., & Powell, W. J., Jr. (1984). The effect of Puerarin on the regional coronary blood flow and heart arterial blood flow dynamics of the acute myocardial ischemia dogs. Acta. Pharm. Sin., 19, 801-807.
15. Mei, L., Ni, L., Daping, M., Yanrong, G., & Yuanhua, C. (2000). Study on the pharmacokinetics of Puerarin in patients with diabetic nephropathy. Clin. J. Hosp. Pharm., 20(12), 718-720.
16. Payne, N. I., Cosgrove, R. F., Green, A. P., & Liu, L. (1987). In vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice. J. Pharm. Pharmacol., 39(1), 24-28.
17. 1H-NMR and TLC. J. Weifang. Med. Coll., 23(1), 4-5.
18. Qinglei, Z., & Xinran, L. (1997). The pharmacology and clinical application of Puerarin. Clin. Trad. Herb. Drugs., 28(11), 693-696.
19. Xiaoying, L., Peiren, W., & Jianhua, S. (1985). The influence of Puerarin on the infarction area in patients with acute myocardial infarction. Clin. J. Cardio., 13, 175-178.
20. Xilu, J., & Xiuyuan, Z. (1992). Pharmacokinetics of Puerarin in rats, rabbits and dogs. Acta. Pharm. Sin., 13(3), 284-288.
21. Xilu, J., Guifang, C., & Xiuyuan, Z. (1991). Pharmacokinetics of Puerarin in healthy volunteers. Clin. J. Clin. Pharmacol., 7(2), 115-118.
22. Xilu, J., Xiuyuan, Z., Wenjie, W., & Guifang, C. (1997). Dertermination of Puerarin in plasma by high performance liquid chromatography. Acta. Pharm., 32(10), 782-785.
23. Xiuyuan, Z. (1979). The metabolism of the effective constituents in Pueraria lobata - the metabolism and pharmacokinetic of Puerarin. Acta. Pharm. Sin., 14, 339.
24. Yasuda, T., Kano, Y., Saito, K., & Ohsawa, K. (1995). Urinary and bilary metabolites of Puerarin in rats. Bio. Pharm. Bull., 18(2), 300-303.
25. Yasuda, T., Ohtsubo, S., Kano, J., & Ohsawa, K. (1995). Facal metabolites after oral administration of major components of Puerariae radix in rats. Annu. Rep. Tohoku Coll. Pharm., 42, 191.
26. Yongnan, J., Hongying, M., & Jimin, C. (2002). Study on pharmacokinetic of herba epimeddi total flavonoids and their phytosomes in rats. Clin. J. Hosp. Pharm., 22(10), 582-585.
27. Yunshu, M., Haoru, Z., & Yining, L. (2000). Studies on permeation of Puerarin and its phospholipid complex through rat skin in vitro. Clin. J. Chin. Mat. Med., 25(5), 274-276.
28. Zhenghong, W., Yanqin, Z., Hanying, Y., & Guang, C. (1999). The study on the solubility of Puerarin and the solubilizing effect of macromolecule polymers on it. Clin. Trad. Herb. Drugs., 30(supplement), 88-89.